Arena Capital Advisors, LLC- CA - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 70 filers reported holding BIOTECH ACQUISITION COMPANY in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Arena Capital Advisors, LLC- CA ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$3,029,970
+1.7%
300,0000.0%1.65%
+83.0%
Q3 2022$2,978,000
+0.3%
300,0000.0%0.90%
+20.5%
Q2 2022$2,970,000
+0.4%
300,0000.0%0.75%
+67.0%
Q1 2022$2,958,000
+0.2%
300,0000.0%0.45%
+65.1%
Q4 2021$2,952,000
+1.0%
300,0000.0%0.27%
+17.7%
Q3 2021$2,922,000
+210.5%
300,000
+208.4%
0.23%
+196.2%
Q2 2021$941,00097,2720.08%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q3 2022
NameSharesValueWeighting ↓
RiverPark Advisors, LLC 799,001$7,930,0002.58%
Corbin Capital Partners, L.P. 928,124$9,207,0002.29%
Cohanzick Management, LLC 799,001$7,926,0001.92%
RPO LLC 379,021$3,762,0000.91%
Arena Capital Advisors, LLC- CA 300,000$2,978,0000.90%
Alpha Wave Global, LP 532,570$5,286,0000.62%
MIZUHO SECURITIES USA LLC 444,957$4,383,0000.60%
MMCAP International Inc. SPC 599,321$5,945,0000.47%
GLAZER CAPITAL, LLC 2,285,000$22,667,0000.42%
CVI Holdings, LLC 292,563$2,904,0000.22%
View complete list of BIOTECH ACQUISITION COMPANY shareholders